- Home
- CSTL vs ARKO Comparison
CSTL vs ARKO Comparison
Compare CSTL & ARKO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CSTL
- ARKO
- Stock Information
- Founded
- CSTL 2007
- ARKO 1970
- Country
- CSTL United States
- ARKO United States
- Employees
- CSTL N/A
- ARKO N/A
- Industry
- CSTL Medical Specialities
- ARKO Oil Refining/Marketing
- Sector
- CSTL Health Care
- ARKO Energy
- Exchange
- CSTL Nasdaq
- ARKO Nasdaq
- Market Cap
- CSTL 456.2M
- ARKO 501.4M
- IPO Year
- CSTL 2019
- ARKO N/A
- Fundamental
- Price
- CSTL $20.49
- ARKO $4.50
- Analyst Decision
- CSTL Strong Buy
- ARKO Buy
- Analyst Count
- CSTL 6
- ARKO 4
- Target Price
- CSTL $37.67
- ARKO $7.19
- AVG Volume (30 Days)
- CSTL 449.7K
- ARKO 602.2K
- Earning Date
- CSTL 08-04-2025
- ARKO 08-05-2025
- Dividend Yield
- CSTL N/A
- ARKO 2.81%
- EPS Growth
- CSTL N/A
- ARKO N/A
- EPS
- CSTL N/A
- ARKO 0.03
- Revenue
- CSTL $347,083,000.00
- ARKO $8,488,413,000.00
- Revenue This Year
- CSTL N/A
- ARKO N/A
- Revenue Next Year
- CSTL $1.36
- ARKO N/A
- P/E Ratio
- CSTL N/A
- ARKO $164.10
- Revenue Growth
- CSTL 38.43
- ARKO N/A
- 52 Week Low
- CSTL $15.45
- ARKO $3.51
- 52 Week High
- CSTL $35.84
- ARKO $7.84
- Technical
- Relative Strength Index (RSI)
- CSTL 67.41
- ARKO 44.82
- Support Level
- CSTL $18.18
- ARKO $4.15
- Resistance Level
- CSTL $20.63
- ARKO $4.51
- Average True Range (ATR)
- CSTL 0.78
- ARKO 0.23
- MACD
- CSTL 0.22
- ARKO -0.02
- Stochastic Oscillator
- CSTL 85.79
- ARKO 16.03
About CSTL Castle Biosciences Inc.
Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. It also provides DecisionDx-UM, a risk stratification GEP test. The company also offers its products to the skin cancer and gastroenterology markets.
About ARKO ARKO Corp.
ARKO Corp owns and operates convenience stores in the United States. Some of its regional store brands include Stop, Admiral, Apple Market, BreadBox, E-Z Mart, fas mart, Li'l Cricket, and Next Door Store. Its retail store offers hot food service, beverages, cigarettes & other tobacco products, candy, salty snacks, grocery, beer, and general merchandise. ARKO operates in four segments: Retail segment, Wholesale segment, fleet fueling segment, and GPM Petroleum segment. The company derives the majority of its revenue from retail and wholesale distribution of fuel.